Kinesis is a specialized investment and communications firm
focused on early-stage life science companies.
MARC HEAL
Managing and Business Director
Kinesis combines deep sector expertise with proven marketing excellence and privileged investor contacts. Through our comprehensive suite of services—from pitch deck development to brand strategy and investor contact — we help life science companies achieve higher valuations, faster funding cycles, and stronger market positioning.
Who we are
The Kinesis team is based in Silicon Valley, USA and London, UK, enabling profitable arbitrage of both services and opportunity. We combine scientific literacy with marketing excellence, ensuring every communication and investment strategy is commercially compelling.
Our team is supported by an extensive network of industry advisors, including former executives from blue chip pharmaceutical companies and high-level investment professionals who provide strategic guidance and direct contact with investment capital.
MARK DECENA
Creative Director
RON WALTER
Brand Director
JOE RIDER
Strategy Director
LIAM BUNSTON
Brand and Motion Graphics Lead
MICHAEL MAVOR
Digital Marketing Lead
Our sister company is Kontent Films
OUR SERVICES
Kinesis offers a comprehensive service portfolio addressing every aspect of life science marketing and investment positioning, from initial brand development through successful funding and market launch.
SELECTED CASE STUDIES
SYFA - INNOVATION IN WELLNESS
Challenge
SYFA, a biotechnology-enhanced wellness company, needed to position their proprietary SYENCE™ platform technology within the life science investment ecosystem and differentiate from traditional supplement companies.
Solution
A comprehensive positioning strategy emphasizing SYFA's patented biotechnology platform, clinical validation approach, and 185x bioavailability improvement metrics. We positioned SYFA as a biotech-adjacent innovator bridging pharmaceutical-grade technology with consumer wellness applications.
Results
SYFA achieved a £9.5M Series A valuation with biotech-focused investors, generated £1M revenue within four weeks of product launch, secured 68% consumer approval in clinical testing, established partnerships with research organizations, and built a robust intellectual property portfolio.
MYOVANT SCIENCES - CHALLENGER BRAND MARKETING
Challenge
Myovant Sciences, a challenger in the cancer treatment space, needed bold communication strategies to raise the profile of their prostate cancer medication, Relugolix, given that 1 in 8 men will develop prostate cancer during their lifetimes, yet are often unwilling to seek consultation.
Solution
A communication strategy designed to encourage openness and discussion of the condition. We filmed groups of real prostate cancer patients sharing their experiences, encouraging and supporting each other. The resulting videos yielded emotional candour while directing patients to supportive prostate cancer resources on Myovant-owned media.
Results
The video series and surrounding digital marketing campaigns yielded stunning engagement and category awareness improvements.
UCSF COLLABORATION - ACADEMIC-COMMERCIAL BRIDGE
Challenge
Within UCSF, autonomous groups were creating off-brand marketing material. We created guidelines for video content creation and implementation to maintain UCSF brand integrity while permitting independence and freedom of action.
Solution
Creation of a comprehensive set of video production and distribution guidelines that were adopted across the organization. This included best-practice production advice, graphics and brand assets, and rigorous frameworks and templates for implementation of text, titling, and UCSF brand assets.
Results
The collaboration led to improved brand integrity across all UCSF teams while allowing autonomy and empowering local groups within the organization.